Skip to main content
SpringerLink
Log in

Prevention of Thromboembolism in Atrial Fibrillation: When Antiplatelet Agents and When Anticoagulants?

  • Chapter
Cardiac Arrhythmias 1997

  • 86 Accesses

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation. N Engl J Med 306: 1018–1022

    Article  PubMed  CAS  Google Scholar 

  2. Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A (1995) Antithrombotic therapy in atrial fibrillation. Fourth ACCP Consensus Conference on Antithrombotic Therapy. Chest 108 (suppl): 352S - 359S

    Article  PubMed  CAS  Google Scholar 

  3. Prytosky EN, Benson DW, Fuster V, Hart RG, Kay GN, Myerburg RJ, Naccarelli GV, Wyse DG (1996) Management of patients with atrial fibrillation. A statement for healthcare professionals from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 93: 1262–1277

    Google Scholar 

  4. Cerebral Embolism Task Force (1989) Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol 46: 727–743

    Google Scholar 

  5. Petersen P (1990) Thromboembolic complications in atrial fibrillation. Stroke 21: 4–13

    Article  PubMed  CAS  Google Scholar 

  6. Cairns JA, Connolly SJ (1991) Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy. Circulation 84: 469–481

    Google Scholar 

  7. Hart RG (1992) Thromboembolism in nonrheumatic atrial fibrillation: what have we learned? In: Di Pasquale G, Pinelli G (eds) Heart-brain interactions. Springer, Berlin Heidelberg, pp 83–86

    Chapter  Google Scholar 

  8. The National Heart, Lung and Blood Institute Working Group on Atrial Fibrillation (1993) Atrial fibrillation: current undestandings and research imperatives. J Am Coll Cardiol 32: 1830–1834

    Google Scholar 

  9. Hart RG, Halperin JL (1994) Atrial fibrillation and stroke: revisiting the dilemmas. Stroke 25: 1337–1341

    Article  PubMed  CAS  Google Scholar 

  10. Stein B, Fuster V, Halperin JL, Chesebro JH (1989) Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk. Circulation 80: 15011513

    Google Scholar 

  11. Chesebro JH, Fuster V, Halperin JL (1991) Atrial fibrillation: risk marker for stroke. N Engl J Med 323: 1556–1558

    Article  Google Scholar 

  12. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B (1989) Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1: 175–179

    Google Scholar 

  13. The Stroke Prevention in Atrial Fibrillation Investigators (1991) The Stroke Prevention in Atrial Fibrillation trial: final results. Circulation 84: 527–539

    Article  Google Scholar 

  14. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 325: 1505–1511

    Google Scholar 

  15. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C, for the CAFA study coinvestigators (1991) Canadian Atrial Fibrillation Anticoagulation ( CAFA) study. J Am Coll Cardiol 18: 349–355

    Google Scholar 

  16. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ, Rickles FR, Shabetai R, Deykin D, for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators (1992) Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. N Engl J Med 327: 1406–1412

    CAS  Google Scholar 

  17. The Stroke Prevention in Atrial Fibrillation Investigators (1992) Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 116: 1–5

    Article  Google Scholar 

  18. Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 154: 1449–1457

    Article  Google Scholar 

  19. Di Pasquale G, Urbinati S, Ribani MA, Passarelli P, Pinelli G (1994) Clinical markers of embolic risk in patients with atrial fibrillation. G Ital Cardiol 24: 315–324

    PubMed  Google Scholar 

  20. Kopecky Sl, Gersh BJ, Mc Goon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM, Frye RL (1987) The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 327: 1406–1412

    Google Scholar 

  21. The Stroke Prevention in Atrial Fibrillation Investigators (1992) Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 116: 6–12

    Article  Google Scholar 

  22. Di Pasquale G, Urbinati S, Pinelli G (1995) “New echocardiographic markers of embolic risk in atrial fibrillation”. Cerebrovasc Dis 5: 315–322

    Article  Google Scholar 

  23. Stroke Prevention in Atrial Fibrillation Investigators (1994) Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 346: 687–691

    Google Scholar 

  24. European Atrial Fibrillation Trial (EAFT) Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342: 1255–1262

    Google Scholar 

  25. Cataldo G, SIFA Study Group (1995) Secondary prevention of stroke in non-valvular atrial fibrillation: results of the SIFA (Studio Italiano Fibrillazione Atriale). J Am Coll Cardiol (Suppl) 144A (abstr)

    Google Scholar 

  26. Patrono C (1994) Aspirin as an antiplatelet drug. N Engl J Med 330: 1287–1294

    Article  PubMed  CAS  Google Scholar 

  27. Miller VT, Rothrock JF, Pearce LA, Feinberg WM, Hart RG, Anderson DC (1993) Ischemic stroke in patients with atrial fibrillation: clinical characteristics and the effect of aspirin. Neurology 43: 32–36

    Article  PubMed  CAS  Google Scholar 

  28. Stroke Prevention in Atrial Fibrillation Investigators (1996) Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 348: 633–638

    Article  Google Scholar 

  29. Di Pasquale G, Ribani MA, Urbinati S, Passarelli P, Pinelli G (1995) Come si deve trattare oggi la fibrillazione atriale. In: Prati PL (ed) Conoscere e curare it cuore ’85. CIBA Edizioni, Milano, pp 285–299

    Google Scholar 

  30. Palareti G, Leali N, Coccheri S et al on behalf of the Italian Study on Complications of Oral Anticoagulant Therapy (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study ( ISCOAT ). Lancet 348: 423–428

    Google Scholar 

  31. Hylek EM, Skates SJ, Sheehan MA, Singer DE (1996) An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 335: 540–546

    Article  PubMed  CAS  Google Scholar 

  32. Gage BF, Cardinalli AB, Albers GW, Owens DK (1995) Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation JAMA 274: 1839–1845

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione di Cardiologia, Ospedale di Bentivoglio, Bologna, Italy

    G. Di Pasquale, S. Biancoli, L. G. Pancaldi, A. Pozzati, S. Vinelli, B. Sassone & F. Ottani

  2. Ospedale Bellaria, Bologna, Italy

    G. Pinelli & S. Urbinati

Authors
  1. G. Di Pasquale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Pinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Urbinati
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Biancoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. G. Pancaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Pozzati
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Vinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B. Sassone
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. F. Ottani
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Divisione di Cardiologia, Ospedale Umberto I, Via Circonvallazione 50, I-30174, Venezia Mestre, Italy

    Antonio Raviele MD

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Italia

About this chapter

Cite this chapter

Di Pasquale, G. et al. (1998). Prevention of Thromboembolism in Atrial Fibrillation: When Antiplatelet Agents and When Anticoagulants?. In: Raviele, A. (eds) Cardiac Arrhythmias 1997. Springer, Milano. https://doi.org/10.1007/978-88-470-2288-1_17

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2288-1_17

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2290-4

  • Online ISBN: 978-88-470-2288-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation